Your browser doesn't support javascript.
loading
Anti-Cancer Activity of Acriflavine as Metabolic Inhibitor of OXPHOS in Pancreas Cancer Xenografts.
Bulle, Ashenafi; Dekervel, Jeroen; Deschuttere, Lise; Nittner, David; Van Cutsem, Eric; Verslype, Chris; van Pelt, Jos.
Afiliação
  • Bulle A; Laboratory of Clinical Digestive Oncology, Department of Oncology, KU Leuven & University Hospitals Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
  • Dekervel J; Laboratory of Clinical Digestive Oncology, Department of Oncology, KU Leuven & University Hospitals Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
  • Deschuttere L; Laboratory of Clinical Digestive Oncology, Department of Oncology, KU Leuven & University Hospitals Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
  • Nittner D; Histopathology Expertise Center, VIB-KU Leuven Center for Cancer Biology, VIB, Leuven, Belgium.
  • Van Cutsem E; Department of Oncology, KU Leuven, Leuven, Belgium.
  • Verslype C; Laboratory of Clinical Digestive Oncology, Department of Oncology, KU Leuven & University Hospitals Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
  • van Pelt J; Laboratory of Clinical Digestive Oncology, Department of Oncology, KU Leuven & University Hospitals Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium.
Onco Targets Ther ; 13: 6907-6916, 2020.
Article em En | MEDLINE | ID: mdl-32764982

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Onco Targets Ther Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Bélgica

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Onco Targets Ther Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Bélgica